Innovation in Ireland → ▾
Partner, Third Rock Ventures
Founder, Young Inventors
VP of Venture Capital, Pfizer Inc.
Former CEO, Calistoga Pharmaceuticals
Co-Founder, VP of Technology, Entropic Communications
Co-Founder and CEO, Wetpaint
CEO and Fund Manager, Renaissance Venture Capital Fund
Shawn Iadonato is chief scientific officer of Kineta
The U.S. Congress is on track to fund a pivotal element of healthcare reform, a $50 million dollar down payment on the $500 million dollar Cures Acceleration Network (CAN) initiative. This... Read more »
Boston · 11/18/1410:00 am - 3:45 pm
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2014, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.